Proud to announce we have strategically invested in Wonder Scientific, a very talented group of researchers and product development experts who are creating custom, naturally derived, APIs (active pharmaceutical ingredients) for the clinical and commercial demand for psychedelics.
Entheon Biomedical Announces CRO Agreement with CHDR for Phase 1 Clinical Trial, Centre for Human Drug Research led DMT study to start in 2021
Entheon Announces Completion of Amalgamation and Final Approval from the Canadian Securities Exchange
Original Source - Newsfile Corp. Vancouver,...
With all eyes on the American election, we are sure that those in the psychedelic medicine sphere wonder what this could mean for the future of psychedelic medicine in the United States. Here’s our stance.
MONTRÉAL, 28 oct. 2020 (GLOBE NEWSWIRE) --...
MPV Exploration Inc. (“MPV” or the “Company”) is pleased to announce that further to its news releases dated July 2, 2020 and September 10, 2020 (the “Initial News Releases”), the Company has received conditional approval from the Canadian Securities Exchange (“CSE”)
Canada appears to be taking a progressive yet patchworked community healthcare approach to alleviating the current opioid and substance-use crisis. But will this alleviate or reduce the number of barriers to safe and effective treatment, or do Canadian patients need and deserve more?
The toll of the opioid crisis in Canada is multi-layered, affecting family and home life and rippling outward to our civic institutions and the economy as a whole. Learn more about these effects and how Entheon Biomedical sees hope through psychedelic-assisted therapy.
See why Entheon’s Chief Science Officer and Director of Operations sees psychedelics are a prominent tool that we should be leveraging for mental health treatments.
What made Entheon stand out to this Project Manager and why does he call the company “The FDAs Dream”? Those questions and more, answered here.
Opioids don’t discriminate—opioid misuse affects all Canadians. Read researcher Jessica Cadoch’s article on how access to treatments for opioid dependency serves communities disproportionately, and how psychedelics offer hope for a more fair, effective and democratic solution.
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a psychedelic substance that can be found in plants (Pachter et al. 1959), the secretion of the Incilius Alvarius toad (Weil and Davis 1994), and made synthetically (Hoshino 1936). The substance is well-known for its short-acting properties (depending on the route of administration) with subjective effects summarized in the following soundbite: ‘we are all on
In the last six months, in the face of the COVID-19 pandemic, we have seen a spike in opioid overdoses, adding more layers of destruction and devastation on an already about isolated, uncertain, and grieving society due to the distancing measures, deaths and job losses that hallmarked this pandemic.
Having just closed a successful raise, we spoke to Timothy Ko about Entheon’s plans for the near future, and the challenges his team may face.
At Imperial College we’ve been comparing psilocybin to conventional antidepressants – and the results are likely to be game-changing. – Robin Carhart-Harris
Psychedelic Finance Spotlight: Timothy Ko | CEO, Entheon Biomedical
Does pharmaceuticalizing the DMT experience make it more accessible, or detract from the therapeutic value of ego death and mysticism?
Are Shrooms And Other Psychedelics The Next Big Thing? This Former Biogen And Pfizer Exec Thinks So
This isn’t the psychedelic you remember from...
Read this article on Benzinga Among the biggest...
Study participants at some of the country’s leading medical research centers are going through intense therapy and six-hour psychedelic journeys deep into their minds to do things like quit smoking and worry less
Heroin addiction is blamed on human weakness and social problems and addicts are labeled as criminals. But it is now known that some humans suffer from a lack of natural opiates in the brain, which causes them to seek the illegal remedy of heroin. They are not really criminals; they just need medical supplements.
Traditionally used in shamanistic ceremonies in the Amazon basin, ayahuasca is now also used to help people overcome addictions to drugs and alcohol.
Psychedelic-assisted therapy refers to therapeutic practices involving psychedelic drugs, oftentimes utilizing serotonergic psychedelics such as LSD, psilocybin, dmt, MDMA, mescaline, and 2C-B.
Because of how psychedelics have been portrayed in the media and lumped in with addictive drugs by law enforcement, it can seem paradoxical to most people that you could use psychedelics to treat addiction. But they are remarkably effective.
This series on the psychedelic treatment of addiction is written by Benjamin Taub from psychedelicsforaddiction.com. Here, part one offers an introduction to psychedelic therapy as a treatment for addiction – and subsequent parts provide details on preparing yourself for treatment, undergoing the treatment itself, and post-treatment integration.
The criminalization of people who use psychedelics is rooted in myths that are the vestiges of colonialism and the drug war – and, one by one, those myths are crumbling down.
Several studies are exploring whether drugs such as magic mushrooms could treat addiction to everything from cigarettes to cocaine.
Trials of a psychedelic drug developed as a medicine with the potential to cure addictions are to begin next year.
This talk was given at a local TEDx event, produced independently of the TED Conferences. Robert Rhatigan struggled with alcoholism for over ten years.
In addition to reducing symptoms of depression, the psychedelic drug 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) appears to cause changes in inflammatory biomarkers, according to preliminary research published in the journal Psychopharmacology.
Democratic presidential candidate Andrew Yang says the U.S. should loosen its ban on psychedelic mushrooms.
The movement to decriminalize psychedelics has spread so rapidly this year that it can be hard to keep track. But Decriminalize Nature, the group coordinating many of these initiatives, is up to the task.
The US Food and Drug Administration (FDA) has...
The unmet need in mental health is huge. If psychedelics can reduce that misery, the benefits would be mind-blowing.
A doctor reveals the fascinating story of psychedelic research in 1950s’ Canada and its profound implications in treatment and therapy.